TheStreet Lowers ICU Medical (NASDAQ:ICUI) to C+

TheStreet lowered shares of ICU Medical (NASDAQ:ICUI) from a b- rating to a c+ rating in a research note released on Monday, TheStreetRatingsTable reports.

Several other equities analysts have also recently issued reports on ICUI. BidaskClub cut ICU Medical from a buy rating to a hold rating in a research report on Wednesday. Zacks Investment Research cut ICU Medical from a hold rating to a sell rating in a research report on Wednesday. ValuEngine cut ICU Medical from a hold rating to a sell rating in a research report on Thursday, August 8th. Finally, Raymond James cut ICU Medical from a strong-buy rating to an outperform rating in a research report on Thursday, August 8th. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and one has assigned a buy rating to the stock. The company currently has a consensus rating of Hold and an average price target of $290.50.

Shares of ICUI stock opened at $167.02 on Monday. ICU Medical has a 1 year low of $160.00 and a 1 year high of $312.45. The stock has a market cap of $3.50 billion, a PE ratio of 21.66 and a beta of 0.81. The business’s fifty day moving average is $237.52 and its 200-day moving average is $236.09.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Wednesday, August 7th. The medical instruments supplier reported $1.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.86 by $0.13. ICU Medical had a return on equity of 12.41% and a net margin of 3.56%. The company had revenue of $312.30 million for the quarter, compared to analysts’ expectations of $315.47 million. During the same period last year, the firm earned $2.69 EPS. The firm’s revenue for the quarter was down 13.4% on a year-over-year basis. As a group, sell-side analysts predict that ICU Medical will post 7.21 EPS for the current year.

In related news, CFO Scott E. Lamb sold 25,000 shares of ICU Medical stock in a transaction on Wednesday, June 26th. The stock was sold at an average price of $250.00, for a total value of $6,250,000.00. Following the transaction, the chief financial officer now directly owns 34,984 shares in the company, valued at approximately $8,746,000. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert S. Swinney sold 2,078 shares of ICU Medical stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $165.18, for a total value of $343,244.04. Following the completion of the transaction, the director now owns 17,345 shares in the company, valued at $2,865,047.10. The disclosure for this sale can be found here. Insiders sold a total of 34,661 shares of company stock worth $8,354,148 over the last 90 days. Insiders own 11.40% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Advisory Services Network LLC grew its holdings in shares of ICU Medical by 70.2% in the 2nd quarter. Advisory Services Network LLC now owns 143 shares of the medical instruments supplier’s stock worth $36,000 after acquiring an additional 59 shares during the last quarter. Quadrant Capital Group LLC grew its holdings in shares of ICU Medical by 1,110.5% in the 1st quarter. Quadrant Capital Group LLC now owns 230 shares of the medical instruments supplier’s stock worth $53,000 after acquiring an additional 211 shares during the last quarter. Huntington National Bank grew its holdings in shares of ICU Medical by 15.3% in the 2nd quarter. Huntington National Bank now owns 474 shares of the medical instruments supplier’s stock worth $119,000 after acquiring an additional 63 shares during the last quarter. DRW Securities LLC acquired a new position in shares of ICU Medical in the 2nd quarter worth $204,000. Finally, Smith Moore & CO. acquired a new position in shares of ICU Medical in the 2nd quarter worth $204,000. Institutional investors and hedge funds own 91.31% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Further Reading: How does a margin account work?

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.